Tesamorelin + Ipamorelin combination GHRH/GHS-R framework

HRVdaily

RESEARCHER · P1

Tesamorelin produces the GHRH pathway activation, ipamorelin produces ghrelin receptor activation. Combining both pathways approximates the synergistic GH release documented by Bowers and colleagues for combination protocols.

Different half-lives mean tesamorelin needs the larger frequency.

PROTOCOL PARAMETERS

Compound	Dose	Frequency	Route
Tesamorelin	1mg	Daily	SubQ
Ipamorelin	200mcg	Daily, evening	SubQ

Duration:12 weeks

Goals:Combined GHRH + GHS-R activation per Bowers synergy literature

RELATED COMPOUNDS

◆Tesamorelin ◆Ipamorelin

Comments (0)

No comments yet. Start the thread.

Keep Researching

Compare Prices

Vendor pricing for tesamorelin

Explore Compounds

The full research database

Run the Math

Reconstitution and dosing calculators

← Back to the Asylum feed